Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Genome Biology
|
May 1, 2019
Measuring sequencer size bias using REcount: a novel method for highly accurate Illumina sequencing-based quantification
Daryl M Gohl, Alessandro Magli, John Garbe, et al.
Journal of Digital Imaging
|
May 24, 2021
A Holographic Augmented Reality Interface for Visualizing of MRI Data and Planning of Neurosurgical Procedures
Cristina M Morales Mojica, Jose D Velazco-Garcia, Eleftherios P Pappas, et al.
Frontiers in Immunology
|
June 3, 2026
Serum metabolomic signatures predict clinical outcomes in advanced non-small cell lung cancer treated with pembrolizumab plus platinum-based chemotherapy
Peter May, Christof Winter, Inga Hubrecht, et al.
The Journal of Urology
|
September 18, 2007
Effect of alpha1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort study
Andrew M Harris, Bradley W Warner, John M Wilson, et al.
Annals of Hematology
|
January 8, 2019
Clinical and genetic characterization of de novo double-hit B cell precursor leukemia/lymphoma
Jan A Stratmann, Aaron Becker von Rose, Sebastian Koschade, et al.
Nature Biotechnology
|
July 26, 2016
Systematic improvement of amplicon marker gene methods for increased accuracy in microbiome studies
Daryl M Gohl, Pajau Vangay, John Garbe, et al.
VASA. Zeitschrift Fur Gefasskrankheiten
|
November 14, 2022
Cancer, cancer treatment and aneurysmatic ascending aorta growth within a retrospective single center study
Kathrin Kobus, Bianca Bohmann, Manuel Wilbring, et al.
International Journal of Cancer
|
December 11, 2012
High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells
Juliane Volkmann, Ute Reuning, Martina Rudelius, et al.
Leukemia Research
|
August 25, 2019
Low-dose melphalan in elderly patients with relapsed or refractory acute myeloid leukemia: A well-tolerated and effective treatment after hypomethylating-agent failure
Jan Stratmann, Elisabeth van Kann, Christoph Rummelt, et al.
Therapeutic Advances in Medical Oncology
|
June 9, 2022
Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis
Jan A Stratmann, Radha Timalsina, Akin Atmaca, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Genome Biology
|
May 1, 2019
Measuring sequencer size bias using REcount: a novel method for highly accurate Illumina sequencing-based quantification
Daryl M Gohl, Alessandro Magli, John Garbe, et al.
Journal of Digital Imaging
|
May 24, 2021
A Holographic Augmented Reality Interface for Visualizing of MRI Data and Planning of Neurosurgical Procedures
Cristina M Morales Mojica, Jose D Velazco-Garcia, Eleftherios P Pappas, et al.
Frontiers in Immunology
|
June 3, 2026
Serum metabolomic signatures predict clinical outcomes in advanced non-small cell lung cancer treated with pembrolizumab plus platinum-based chemotherapy
Peter May, Christof Winter, Inga Hubrecht, et al.
The Journal of Urology
|
September 18, 2007
Effect of alpha1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort study
Andrew M Harris, Bradley W Warner, John M Wilson, et al.
Annals of Hematology
|
January 8, 2019
Clinical and genetic characterization of de novo double-hit B cell precursor leukemia/lymphoma
Jan A Stratmann, Aaron Becker von Rose, Sebastian Koschade, et al.
Nature Biotechnology
|
July 26, 2016
Systematic improvement of amplicon marker gene methods for increased accuracy in microbiome studies
Daryl M Gohl, Pajau Vangay, John Garbe, et al.
VASA. Zeitschrift Fur Gefasskrankheiten
|
November 14, 2022
Cancer, cancer treatment and aneurysmatic ascending aorta growth within a retrospective single center study
Kathrin Kobus, Bianca Bohmann, Manuel Wilbring, et al.
International Journal of Cancer
|
December 11, 2012
High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells
Juliane Volkmann, Ute Reuning, Martina Rudelius, et al.
Leukemia Research
|
August 25, 2019
Low-dose melphalan in elderly patients with relapsed or refractory acute myeloid leukemia: A well-tolerated and effective treatment after hypomethylating-agent failure
Jan Stratmann, Elisabeth van Kann, Christoph Rummelt, et al.
Therapeutic Advances in Medical Oncology
|
June 9, 2022
Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis
Jan A Stratmann, Radha Timalsina, Akin Atmaca, et al.
Page
of 3